AngioGenex
New York, US · Nevada corporation
Biotech
Founders & leadership
MM
Martin MurrayExecutive Officer, Director
MA
Michael AronsteinExecutive Officer, Director
MS
Michael StrageExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$260KraisedDec 2021 · 1 investors · PharmaceuticalsRule 506(b)
Officers, directors & promoters on the filing
- Martin MurrayExecutive Officer, Director
- Michael AronsteinExecutive Officer, Director
- Michael StrageExecutive Officer, Director
- Offering amount
- $260K
- Amount sold
- $260K
- First sale
- Dec 2021
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.